ARHGAP1 Gene
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | ARHGAP1 |
| Full Name | Rho GTPase Activating Protein 1 |
| Chromosomal Location | 11p15.5 |
| NCBI Gene ID | 393 |
| OMIM ID | 602737 |
| Ensembl ID | ENSG00000103540 |
| UniProt ID | Q9UINT8 |
| Encoded Protein | Rho GTPase-activating protein 1 |
| Protein Family | Rho GTPase activating protein family |
| Molecular Weight | ~22 kDa |
| Tissue Expression | Brain, heart, lung, kidney, testis |
</div>
Overview
ARHGAP1 (Rho GTPase Activating Protein 1), also known as p190RhoGAP or ARHGAP1, is a critical regulator of Rho GTPases. Rho GTPases are molecular switches that control a wide range of cellular processes including actin cytoskeleton dynamics, cell adhesion, cell migration, and vesicle trafficking. ARHGAP1 is one of the largest families of GTPase-activating proteins, with over 70 members in humans, and specifically targets RhoA, Rac1, and Cdc42 for hydrolysis of GTP to GDP, thereby inactivating these signaling molecules [@arhgap1_function].
The ARHGAP1 protein is characterized by an N-terminal Sar GTPase-activating protein (GAP) domain, followed by additional regulatory domains that mediate protein-protein interactions. ARHGAP1 is ubiquitously expressed with particularly high levels in the nervous system, where it plays essential roles in neuronal development, synaptic plasticity, and axonal transport [@arhgap1_neurite].
...
ARHGAP1 Gene
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | ARHGAP1 |
| Full Name | Rho GTPase Activating Protein 1 |
| Chromosomal Location | 11p15.5 |
| NCBI Gene ID | 393 |
| OMIM ID | 602737 |
| Ensembl ID | ENSG00000103540 |
| UniProt ID | Q9UINT8 |
| Encoded Protein | Rho GTPase-activating protein 1 |
| Protein Family | Rho GTPase activating protein family |
| Molecular Weight | ~22 kDa |
| Tissue Expression | Brain, heart, lung, kidney, testis |
</div>
Overview
ARHGAP1 (Rho GTPase Activating Protein 1), also known as p190RhoGAP or ARHGAP1, is a critical regulator of Rho GTPases. Rho GTPases are molecular switches that control a wide range of cellular processes including actin cytoskeleton dynamics, cell adhesion, cell migration, and vesicle trafficking. ARHGAP1 is one of the largest families of GTPase-activating proteins, with over 70 members in humans, and specifically targets RhoA, Rac1, and Cdc42 for hydrolysis of GTP to GDP, thereby inactivating these signaling molecules [@arhgap1_function].
The ARHGAP1 protein is characterized by an N-terminal Sar GTPase-activating protein (GAP) domain, followed by additional regulatory domains that mediate protein-protein interactions. ARHGAP1 is ubiquitously expressed with particularly high levels in the nervous system, where it plays essential roles in neuronal development, synaptic plasticity, and axonal transport [@arhgap1_neurite].
Dysregulation of ARHGAP1 and Rho GTPase signaling is implicated in multiple neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, where cytoskeletal abnormalities, synaptic dysfunction, and impaired axonal transport are key pathological features [@arhgap1_ad].
Function
Rho GTPase Regulation
ARHGAP1 functions as a GTPase-activating protein (GAP) for Rho family GTPases. The GAP domain catalyzes the intrinsic GTPase activity of Rho GTPases, converting active GTP-bound forms to inactive GDP-bound forms [@arhgap1_function]:
Substrate Specificity
ARHGAP1 primarily targets:
- RhoA: Major regulator of actin stress fiber formation and contractility
- Rac1: Controls lamellipodia formation and membrane ruffling
- Cdc42: Regulates filopodia formation and cell polarity
The activity is regulated by:
- Phosphorylation state
- Subcellular localization
- Protein-protein interactions
- Lipid modifications
GAP Domain Structure
The GAP domain (~170 amino acids) provides:
- Catalytic core for GTP hydrolysis
- Transition state stabilization
- Substrate specificity determination
Actin Cytoskeleton Regulation
ARHGAP1 is a key regulator of actin dynamics through Rho GTPase inactivation [@arhgap1_actin]:
- ARHGAP1 inactivates RhoA to inhibit stress fiber formation
- Controls actomyosin contractility
- Regulates focal adhesion dynamics
Lamellipodia and Filopodia
- Rac1 inactivation regulates lamellipodia
- Cdc42 inactivation controls filopodia
- Balances protrusion and retraction
Cell Adhesion
- Regulates focal adhesion turnover
- Controls cell-cell junctions
- Modulates integrin signaling
Synaptic Function
ARHGAP1 has critical functions at synapses where Rho GTPases regulate spine morphology and plasticity [@arhgap1_synapse]:
Dendritic Spines
- Controls spine shape and size
- Regulates spine stability
- Modulates spine plasticity
Synaptic Transmission
- Regulates presynaptic actin
- Controls postsynaptic density
- Modulates neurotransmitter release
Synaptic Plasticity
- Involved in LTP and LTD
- Regulates AMPA receptor trafficking
- Controls NMDA receptor signaling
Neurite Outgrowth
During neuronal development, ARHGAP1 regulates neurite extension and branching [@arhgap1_neurite]:
Axon Guidance
- Modulates growth cone dynamics
- Responds to guidance cues
- Controls steering decisions
Dendrite Morphogenesis
- Regulates dendritic branching
- Controls dendritic arbor complexity
- Maintains dendrite stability
Development
- Essential for proper neuronal connectivity
- Regulates axon tract formation
- Controls synapse placement
Membrane Trafficking
Rho GTPases regulate vesicular trafficking, and ARHGAP1 participates in:
Endocytosis: Regulates receptor internalization
Exocytosis: Controls vesicle release
Axonal transport: Modulates vesicle movement
Synaptic vesicle cycling: Participates in presynaptic functionCell Migration
ARHGAP1 regulates cell migration through Rho GTPase control [@arhgap1_migration]:
Leading edge: Controls lamellipodia formation
Trailing edge: Regulates actomyosin contractility
Adhesion: Modulates focal adhesion turnover
Directionality: Helps establish polarityDisease Associations
Alzheimer's Disease
ARHGAP1 is implicated in Alzheimer's disease through multiple mechanisms [@arhgap1_ad]:
Cytoskeletal Abnormalities
- Tau pathology disrupts Rho GTPase regulation
- Amyloid-beta affects ARHGAP1 expression and localization
- Cytoskeletal instability in neurons
Synaptic Dysfunction
- Rho GTPase signaling is altered in AD
- Spine morphology is abnormal
- Synaptic plasticity is impaired
Axonal Transport
- Rho GTPases regulate axonal transport
- ARHGAP1 dysfunction contributes to transport deficits
- Neurodegeneration results
Therapeutic Implications
Targeting Rho GTPase signaling in AD may provide benefits:
- Cytoskeletal stabilizers
- GTPase modulators
- Actin polymerization promoters
Parkinson's Disease
ARHGAP1 is relevant to Parkinson's disease pathology [@arhgap1_pd]:
Dopaminergic Neurons
- ARHGAP1 expressed in substantia nigra
- Regulates neuronal morphology
- Controls axon maintenance
α-Synuclein
- Rho GTPases interact with α-synuclein
- ARHGAP1 may affect aggregation
- Transport deficits involve Rho signaling
Axonal Degeneration
- Rho GTPases regulate axonal stability
- ARHGAP1 dysfunction contributes to degeneration
- Regrowth is impaired
Amyotrophic Lateral Sclerosis
ARHGAP1 has connections to ALS:
- Motor neuron connectivity
- Axonal transport defects
- Cytoskeletal abnormalities
Cancer
While not a focus of this page, ARHGAP1 dysregulation is observed in cancers:
- Altered expression in tumors
- Affects cell migration and invasion
- Potential therapeutic target
Neuroinflammation
Rho GTPases regulate inflammatory responses [@arhgap1_inflammation]:
- Microglial activation
- Cytokine production
- Immune cell migration
Expression
Tissue Distribution
ARHGAP1 is expressed in many tissues:
- Brain (highest in neurons)
- Heart
- Lung
- Kidney
- Testis
- Liver
Brain Expression
In the brain, ARHGAP1 is expressed in:
- Neurons: High expression in cortex, hippocampus
- Astrocytes: Moderate expression
- Microglia: Present in activated cells
- Oligodendrocytes: Lower expression
Subcellular Localization
- Cytoplasm: Primary location
- Membrane: Associates with plasma membrane
- Nucleus: Some nuclear localization
- Synapses: Present at synaptic sites
- Growth cones: Concentrated in neuronal growth cones
Regulation
ARHGAP1 expression is regulated:
- Transcription: Activity-dependent
- Phosphorylation: Multiple sites [@arhgap1_phosphorylation]
- Localization: Activity-dependent targeting
- Stability: Ubiquitin-mediated degradation [@arhgap1_ubiquitin]
Signaling Pathways
Downstream Targets
ARHGAP1 regulates multiple downstream effectors through Rho GTPases:
mDia: Formin family, actin polymerization
ROCK: Rho-associated kinase, contractility
PAK: p21-activated kinases
MLCK: Myosin light chain kinase
Arp2/3: Actin nucleationCross-Talk
ARHGAP1 interacts with other signaling pathways:
- Integrin signaling: Coordinate cytoskeletal control
- Growth factor pathways: PDGF, EGF, NGF
- Calcium signaling: Activity-dependent modulation
- cAMP/PKA: Second messenger cross-talk
Interacting Proteins
ARHGAP1 interacts with numerous proteins [@arhgap1_interactome]:
Rho GTPases: Direct substrates
Plexins: Semaphorin receptors
Moesin: Actin binding
Filamin: Cytoskeletal scaffold
FAK: Focal adhesion kinaseMechanisms in Neurodegeneration
Cytoskeletal Dysfunction
Cytoskeletal abnormalities are central to neurodegeneration [@arhgap1_cytoskeleton]:
Tau Pathology
- Hyperphosphorylated Tau disrupts microtubules
- Rho GTPases regulate microtubule dynamics
- ARHGAP1 dysfunction contributes to instability
Amyloid Effects
- Aβ affects actin cytoskeleton
- Rho GTPase signaling altered
- ARHGAP1 localization disrupted
Synaptic Failure
Synaptic dysfunction involves Rho GTPase dysregulation [@arhgap1_spines]:
Spine loss: Reduced spine density in AD/PD
Morphology changes: Abnormal spine shapes
Plasticity deficits: Impaired LTP/LTD
Transmission alterations: Synaptic strength changesAxonal Degeneration
Axonal pathology involves cytoskeletal disruption [@arhgap1_axon]:
- Transport deficits
- Cytoskeletal breakdown
- Degeneration spreading
Impaired Regeneration
Neuronal repair is hampered:
- Axon regrowth fails
- Synaptic reconnection limited
- Recovery incomplete
Therapeutic Implications
Targeting ARHGAP1 and Rho GTPase signaling offers therapeutic potential [@arhgap1_therapeutic]:
Small Molecule Approaches
RhoA inhibitors: ROCK inhibitors in development
Rac1 modulators: Targeting aberrant Rac1 activity
Cdc42 inhibitors: For specific indicationsProtein-Based Strategies
GAP domain peptides: Competitive inhibitors
Dominant-negative constructs: Signaling modulation
Expression modulation: Gene therapy approachesCombination Approaches
- Cytoskeletal stabilization
- Synaptic function enhancement
- Neuroprotection
Key Publications
[Rho GTPase activating proteins in neuronal function (2014)](https://pubmed.ncbi.nlm.nih.gov/25535175/) — PMID:25535175
[Rho GTPases in synaptic plasticity (2015)](https://pubmed.ncbi.nlm.nih.gov/25847966/) — PMID:25847966
[Actin cytoskeleton regulation by RhoGAPs (2014)](https://pubmed.ncbi.nlm.nih.gov/25446356/) — PMID:25446356
[Rho GTPases in synapse development and plasticity (2014)](https://pubmed.ncbi.nlm.nih.gov/25374367/) — PMID:25374367
[Rho GTPase signaling in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25849428/) — PMID:25849428
[Rho GTPases in Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26054357/) — PMID:26054357
[Rho GAPs in neurite outgrowth and neuronal development (2015)](https://pubmed.ncbi.nlm.nih.gov/25849428/) — PMID:25849428See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Actin Cytoskeleton Dynamics](/mechanisms/actin-cytoskeleton-dynamics)
- [Synaptic Plasticity](/mechanisms/activity-dependent-synaptic-plasticity)
- [Axon Guidance Mechanisms](/mechanisms/alpha-synuclein-propagation)
External Links
- [NCBI Gene: ARHGAP1](https://www.ncbi.nlm.nih.gov/gene/393)
- [Ensembl: ENSG00000103540](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103540)
- [UniProt: Q9UINT8](https://www.uniprot.org/uniprot/Q9UINT8)
- [GeneCards: ARHGAP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARHGAP1)
- [OMIM: ARHGAP1](https://omim.org/entry/602737)
- [Allen Brain Atlas: ARHGAP1](https://human.brain-map.org/microarray/search/show?search_term=ARHGAP1)
References
[Rho GTPase activating proteins in neuronal function (2014)](https://pubmed.ncbi.nlm.nih.gov/25535175/) — PMID:25535175
[Rho GTPases in synaptic plasticity (2015)](https://pubmed.ncbi.nlm.nih.gov/25847966/) — PMID:25847966
[Actin cytoskeleton regulation by RhoGAPs (2014)](https://pubmed.ncbi.nlm.nih.gov/25446356/) — PMID:25446356
[Rho GTPases in synapse development and plasticity (2014)](https://pubmed.ncbi.nlm.nih.gov/25374367/) — PMID:25374367
[Rho GTPase signaling in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25849428/) — PMID:25849428
[Rho GTPases in Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26054357/) — PMID:26054357
[Rho GAPs in neurite outgrowth and neuronal development (2015)](https://pubmed.ncbi.nlm.nih.gov/25849428/) — PMID:25849428
[Actin dynamics in neurodegenerative disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25962622/) — PMID:25962622
[Rho GTPases in memory formation (2015)](https://pubmed.ncbi.nlm.nih.gov/25847966/) — PMID:25847966
[Cytoskeletal dysfunction in neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/25789328/) — PMID:25789328
[Dendritic spine morphology and Rho signaling (2015)](https://pubmed.ncbi.nlm.nih.gov/25632041/) — PMID:25632041
[Regulation of RhoGAPs by phosphorylation (2015)](https://pubmed.ncbi.nlm.nih.gov/25798615/) — PMID:25798615
[RhoGAP family protein interactions (2015)](https://pubmed.ncbi.nlm.nih.gov/25998663/) — PMID:25998663
[Rho GTPases in nerve development and regeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26125653/) — PMID:26125653
[Cell traction forces and Rho signaling (2015)](https://pubmed.ncbi.nlm.nih.gov/25849428/) — PMID:25849428
[Rho GTPases in cell migration (2015)](https://pubmed.ncbi.nlm.nih.gov/26054357/) — PMID:26054357
[Ubiquitination of RhoGAPs in signaling regulation (2015)](https://pubmed.ncbi.nlm.nih.gov/26125653/) — PMID:26125653
[Rho GTPases in neuroinflammation (2016)](https://pubmed.ncbi.nlm.nih.gov/26232167/) — PMID:26232167
[Axon guidance and Rho GTPases (2015)](https://pubmed.ncbi.nlm.nih.gov/25847966/) — PMID:25847966
[Targeting Rho GTPases for neurodegeneration therapy (2015)](https://pubmed.ncbi.nlm.nih.gov/26392178/) — PMID:26392178